Question 1

Does Ameriprise Financial own INO stock?

Accepted Answer

No. Ameriprise Financial exited its INO (Inovio Pharmaceuticals) position in Q2 2021. Its Q1 2021 13F listed 10,707 shares worth $99,000.

Question 2

How many shares of INO does Ameriprise Financial own?

Accepted Answer

None since Q2 2021, when Ameriprise Financial exited the position. Its Q1 2021 13F listed 10,707 shares worth $99,000.

Question 3

What is Ameriprise Financial's INO position worth?

Accepted Answer

Ameriprise Financial's INO position was worth $99,000 in its Q1 2021 13F, before the exit in Q2 2021.

Question 4

Is Ameriprise Financial buying or selling INO?

Accepted Answer

In Q2 2021, Ameriprise Financial exited its entire INO position.

Question 5

When did Ameriprise Financial first buy INO?

Accepted Answer

Ameriprise Financial already held INO in its Q1 2019 13F, the earliest on record, and listed it in 8 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2021-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$111.24	0
2021-Q1	New	10,707	-	$99,000	0.0%	$111.36	33
2020-Q4	Exited	0	-100.0%	$0	0.0%	$106.20	0
2020-Q3	Increased	11,583	+39.7%	$135,000	0.0%	$139.20	29
2020-Q2	Decreased	8,292	-29.4%	$223,000	0.0%	$323.40	0
2020-Q1	Decreased	11,743	-38.0%	$87,000	0.0%	$89.28	0
2019-Q4	Increased	18,938	+1.4%	$62,000	0.0%	$39.60	14
2019-Q3	Increased	18,683	+27.2%	$38,000	0.0%	$24.60	17
2019-Q2	Unchanged	14,683	0.0%	$43,000	0.0%	$35.28	0
2019-Q1	First report	14,683	-	$55,000	0.0%	$44.76	0

INO10 quarters

INO
10 quarters